Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-17-010623
Filing Date
2017-11-14
Accepted
2017-11-14 16:10:15
Documents
59
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT innv10q_sep302017.htm 10-Q 1091653
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-1.htm EX-31.1 15166
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-2.htm EX-31.2 15149
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE ex32-1.htm EX-32.1 10397
  Complete submission text file 0001654954-17-010623.txt   3818639

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT innv-20170930.xml EX-101.INS 566684
6 XBRL TAXONOMY EXTENSION SCHEMA innv-20170930.xsd EX-101.SCH 49109
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE innv-20170930_cal.xml EX-101.CAL 52724
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE innv-20170930_def.xml EX-101.DEF 106769
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE innv-20170930_lab.xml EX-101.LAB 303122
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE innv-20170930_pre.xml EX-101.PRE 221935
Mailing Address 8845 REHCO ROAD SAN DIEGO CA 92121
Business Address 8845 REHCO ROAD SAN DIEGO CA 92121 858-964-5123
INNOVUS PHARMACEUTICALS, INC. (Filer) CIK: 0001411879 (see all company filings)

EIN.: 900814124 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52991 | Film No.: 171201577
SIC: 2834 Pharmaceutical Preparations